VU Chemical Biology

VICB Seminar Spotlight: Clifton Barry III (NIAID, NIH) Join us for a seminar on the development of MK-7762 and its potential impact on tuberculosis treatment. 📅 June 2 | 4 PM 📍 512 Light Hall Co-hosted with VI4, Adult Infectious Disease, and the Tuberculosis Center at VUMC

🎉 From prioritizing #collaboration and creating a shared #scientificcommunity, to investing deeply in #trainee support and #mentorship, these choices have helped define who we are over the last 10 years. 👉 medschool.vanderbilt.edu/basic-sciences…

🔬 Faculty Spotlight: Craig W. Lindsley, Ph.D. Exec Director, @WCNDD_TN & Editor-in-Chief, Journal of Medicinal Chemistry ACSPublications. 25+ years (@EliLillyandCo, @Merck, @VanderbiltU) 115+ patents | 580+ publications Advancing clinical candidates hubs.li/Q049vt5N0

New VICB publications just dropped 🔬 Check out the latest work: medschool.vanderbilt.edu/vicb/publicati… #Vanderbilt #Science #DrugDiscovery

Congratulations to VICB member, Dr. Ian Macara, who received the 2025 Edward E. Price Jr. Award for Excellence in Basic Research at Vanderbilt’s Research Staff Awards ceremony. Read more: news.vumc.org/2026/05/04/res…

Congratulations to VICB's Dr. @DougKojetin on his promotion to Professor of Biochemistry and to VICB Director, Dr. Doug Mitchell on being named the William Kelly Warren Sr. Chair in Biochemistry! 🎉 🔗 medschool.vanderbilt.edu/basic-sciences…

🧬 A recent study by Emily Hodges & Guoqiang Gu in @NatMetabolism reveals how changes in DNA regulation within pancreatic islet cells may help explain the development of type 2 #diabetes. Read more 👉 nature.com/articles/s4225…

‼️ ATTENTION EARLY CAREER RESEARCHERS ‼️ The PhRMA Foundation's Translational Medicine Program offers predoctoral fellowships, postdoctoral fellowships, and faculty starter grants. Submit your letter of intent by May 27 @ 12pm (noon) ET. Learn more: lnkd.in/gF4T9ZkQ

Congratulations to this year’s V14 Trainees of the Year! 🎉 Audrey Thomas (Borden Lacy Lab) and Kara Eichelberger, PhD (James Cassat Lab) were recognized for the incredible work they’re doing. #trainees #research #congratulations #chemistry

Tina Iverson quoted in: What Physical ‘Life Force’ Turns Biology’s Wheels? quantamagazine.org/what-physical-… via @QuantaMagazine

Faculty like Colleen Niswender highlight what makes the High Throughput Screening Facility a critical partner in advancing discovery. From full project oversight to hands-on screening support. Learn more about HTS: medschool.vanderbilt.edu/vicb/hts/ #research

New publications from VICB members are out now! Highlighting innovative research across chemical biology, molecular mechanisms & therapeutic discovery. Explore the latest work from our community: medschool.vanderbilt.edu/vicb/publicati… #research #highereducation #vanderbilt

🎉 As our school reaches its 10-year milestone, we’re reflecting on the key decisions that helped define who we are today—from building a collaborative, curiosity-driven #research environment to investing in people, training, and #innovation. Read more 👉 medschool.vanderbilt.edu/basic-sciences…

Vanderbilt Health researchers are using a $3.1M grant to develop a noninvasive eye test to detect Alzheimer's disease. Tracking protein flow in retinal vessels with light-emitting nanobodies could spot early signs during a routine eye exam. Read more: bit.ly/4miskMO

What do researchers gain from working with the Molecular Design & Synthesis Core (MDSC)? From molecular design to a connected chemical biology network, MDSC supports researchers at every stage. Discover what MDSC can do for your work: medschool.vanderbilt.edu/vicb/syncore/

🚨 TOMORROW - MAY 1‼️ is the deadline submit your intention of participation in VICB/St. Jude's collaborative research project. Graduate Students and Postdocs are strongly encouraged to particpate! Do not be late!

#Congratulations to VICB Director, Doug Mitchell on being designated a Chartered Chemist (CChem) by the @RoySocChem!

New from VICB member @hamm_heidi : Septagen Pharmaceuticals is advancing a precision medicine approach to women’s heart health pairing targeted therapy with diagnostics to address thromboinflammatory risk. 🔗 futurefemhealth.com/p/vanderbilt-u…

To mark this milestone, we’re launching a five-week celebration series highlighting the people, discoveries, history, and philanthropy that shape who we are. 💛 Join us as we celebrate the past—and look ahead to the future of discovery. medschool.vanderbilt.edu/basic-sciences…

New from the Fesik Lab at @VanderbiltU: Postdoc Dr. Jade Katinas identified novel E3 ligase ligands using NMR-based fragment screening advancing PROTAC #therapy design and expanding the targeted degradation toolbox. 🔗 vanderbilt.edu/csb/2026/04/02…